Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
What Is The Index Level Today explains how the current reading summarizes market performance and sentiment, helping you gauge direction and potential moves short-term.
19,819 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
NVIDIA stock is under pressure as a wave of AI infrastructure spending by the Magnificent Seven tests profits versus ...
A sub-$1 pre-IPO company behind a headset-first work platform says 1.5m+ people spend their work week in headsets. It...
A Federal Reserve study shows the price surge hitting low-income households hardest, revealing a widening gap in ener...
Apple doubles down on returning capital to shareholders with a $100 billion buyback and a dividend hike, while rivals...
Insider activity is part of every bank’s life. This guide explains how to read Form 4 disclosures and what they may m...
Artificial intelligence quarterly earnings are changing how investors digest company reports. This guide explains the...
Stock splitting isn’t just a corporate stunt. It can shift trading dynamics, liquidity, and investor perception. This...
When top executives trim stakes, investors take note. This article breaks down the meaning behind such moves, with a ...
A prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
Independent single-family rental owners are largely insulated from institutional competition, according to TurboTenan...
XRP failed to sustain a move above $1.40 this week, opening the door to downside risk. Here are the latest ripple (xr...